Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Mounjaro

These are related to the Mounjaro news, in which you can learn about the updated information in Mounjaro, to help you better understand and expand Mounjaro market. Because the market for Mounjaro is evolving and changing, so we recommend that you collect our website, and we will show you the latest news on a regular basis.
  • Dual Incretin Revolution: Tirzepatide’s Mechanism And Clinical Impact in Obesity & Diabetes

    Dual Incretin Revolution: Tirzepatide’s Mechanism And Clinical Impact in Obesity & Diabetes

    2025-06-19

    Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents a breakthrough in obesity and type 2 diabetes treatment. This article explores its synergistic mechanism, superior clinical outcomes, and global market potential. It also highlights how Unibest supports global pharma companies with API sourcing, licensing, and regulatory services in the incretin drug space. Read More
  • Drug Briefing: Tirzepatide

    Drug Briefing: Tirzepatide

    2025-05-29

    Query Drug：TirzepatideQuery Time：2025-05-29 16:35:52*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Read More